Pancreatic Cancer
Conditions
Interventions
Experimental group:Ultrasound microbubble technology combined with neoadjuvant therapy (chemotherapy, targeted or immunotherapy) , the treatment time was 30 minutes after neoadjuvant therapyv10min
Control group:Direct routine treatment: chemotherapy, targeted therapy or immunotherapy
Sponsors
Chongqing General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? Pancreatic cancer confirmed by histopathology or cytology; ? Have indications of neoadjuvant therapy, and can tolerate neoadjuvant therapy, including chemotherapy, targeted therapy, immunotherapy; ? Age 18-75 years old, male or female; ? No obvious abnormality of liver and kidney function; ? Cardiopulmonary function is basically normal; ? No history of other malignant tumors; ? Good compliance, no mental disorders.
Exclusion criteria
Exclusion criteria: ? Pregnancy or breast feeding; ? Allergic to chemotherapy, immunotherapy, and targeted therapy drugs; ? being treated with other antitumor drugs; ? Also participate in other clinical trials or chemotherapy completion time is less than 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of ultrasonic cavitation technique on microbubble;Patient prognosis (including tumor recurrence and survival time); | — |
Secondary
| Measure | Time frame |
|---|---|
| The perioperative period; | — |
Countries
China
Contacts
Public ContactHuaizhi Wang
Chongqing General Hospital
Outcome results
None listed